

Core Viewpoint - Canopy Growth Corporation has launched a new at-the-market equity program allowing the issuance and sale of up to US$200 million of common shares to support corporate purposes, including debt repayment and strategic acquisitions [1][2]. Group 1: ATM Program Details - The ATM Program enables Canopy Growth to issue and sell common shares in public offerings in the U.S. and Canada, with sales conducted at prevailing market prices [1]. - The program will remain effective until the earlier of the sale of all shares, regulatory notice of cessation of effectiveness, or July 5, 2026, unless terminated earlier [3]. - The offering is qualified by a prospectus supplement filed with Canadian and U.S. securities regulators [4]. Group 2: Use of Proceeds - Net proceeds from the ATM Program will be utilized for investments in businesses, potential acquisitions, working capital, and general corporate purposes, including a US$100 million optional prepayment under the existing credit agreement [2]. Group 3: Company Overview - Canopy Growth is a leading cannabis company focused on improving lives through cannabis products, with operations in Canada, Germany, Poland, and Australia [6][7]. - The company has established a comprehensive ecosystem to capitalize on the U.S. THC market through non-controlling interests in Canopy USA, which includes ownership stakes in Acreage Holdings and Wana Brands [8].